Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease

The intake of Simvastatin in a dosage of 40 mg daily within two months in patients with ischemia heart disease has caused increase in the general percentage of ω6 fat acids (FA) at a constant level of ω3 FA, that was not accompanied by change of a ratio ω3/ω6 FA. Despite of progressing increase in t...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	V. V. Novitsky [verfasserIn] R. S. Karpov [verfasserIn] M. Yu. Kotlovsky [verfasserIn] S. V. Klemenkov [verfasserIn] O. V. Voronkova [verfasserIn] V. A. Shulman [verfasserIn] S. Yu. Nikulina [verfasserIn] S. V. Mashkovskaya [verfasserIn] D. A. Kirichenko [verfasserIn] Ye. N. Ivtchenko [verfasserIn] A. A. Masterova [verfasserIn] K. V. Zlodeyev [verfasserIn] Yu. V. Kotlovsky [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch ; Russisch

Erschienen:	2008

Schlagwörter:	ишемическая болезнь сердца симвастатин жирные кислоты

Übergeordnetes Werk:	In: Бюллетень сибирской медицины - Siberian State Medical University (Tomsk), 2016, 7(2008), 3, Seite 13-19
Übergeordnetes Werk:	volume:7 ; year:2008 ; number:3 ; pages:13-19

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc Journal toc

DOI / URN:	10.20538/1682-0363-2008-3-13-19

Katalog-ID:	DOAJ084326883

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ084326883
003	DE-627
005	20230410115734.0
007	cr uuu---uuuuu
008	230311s2008 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.20538/1682-0363-2008-3-13-19 \|2 doi
035			\|a (DE-627)DOAJ084326883
035			\|a (DE-599)DOAJ8d5cbe0c1c5d4dfbabafa12fb61f6d66
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng \|a rus
100	0		\|a V. V. Novitsky \|e verfasserin \|4 aut
245	1	0	\|a Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease
264		1	\|c 2008
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a The intake of Simvastatin in a dosage of 40 mg daily within two months in patients with ischemia heart disease has caused increase in the general percentage of ω6 fat acids (FA) at a constant level of ω3 FA, that was not accompanied by change of a ratio ω3/ω6 FA. Despite of progressing increase in total concentration of ω7 FA (at women) and increase of a level ω9 FA (at men) during simvastatin treatment at women and at men led to decrease in the total percentage of nonsaturated fat acids concerning corresponding parameters at healthy donors. The Simvastatin treatment was accompanied by increase in blood plasma in patients with ischemia heart disease (and first of all at women) percentage of the separate saturated fat acids, and also their total level. The index of nonsaturation of fat acids of blood plasma is decreased.
650		4	\|a ишемическая болезнь сердца
650		4	\|a симвастатин
650		4	\|a жирные кислоты
653		0	\|a Medicine
653		0	\|a R
700	0		\|a R. S. Karpov \|e verfasserin \|4 aut
700	0		\|a M. Yu. Kotlovsky \|e verfasserin \|4 aut
700	0		\|a S. V. Klemenkov \|e verfasserin \|4 aut
700	0		\|a O. V. Voronkova \|e verfasserin \|4 aut
700	0		\|a V. A. Shulman \|e verfasserin \|4 aut
700	0		\|a S. Yu. Nikulina \|e verfasserin \|4 aut
700	0		\|a S. V. Mashkovskaya \|e verfasserin \|4 aut
700	0		\|a D. A. Kirichenko \|e verfasserin \|4 aut
700	0		\|a Ye. N. Ivtchenko \|e verfasserin \|4 aut
700	0		\|a A. A. Masterova \|e verfasserin \|4 aut
700	0		\|a K. V. Zlodeyev \|e verfasserin \|4 aut
700	0		\|a Yu. V. Kotlovsky \|e verfasserin \|4 aut
773	0	8	\|i In \|t Бюллетень сибирской медицины \|d Siberian State Medical University (Tomsk), 2016 \|g 7(2008), 3, Seite 13-19 \|w (DE-627)1760628204 \|x 18193684 \|7 nnns
773	1	8	\|g volume:7 \|g year:2008 \|g number:3 \|g pages:13-19
856	4	0	\|u https://doi.org/10.20538/1682-0363-2008-3-13-19 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/8d5cbe0c1c5d4dfbabafa12fb61f6d66 \|z kostenfrei
856	4	0	\|u https://bulletin.ssmu.ru/jour/article/view/3472 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1682-0363 \|y Journal toc \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1819-3684 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
951			\|a AR
952			\|d 7 \|j 2008 \|e 3 \|h 13-19

Indexfelder

author_variant	v v n vvn r s k rsk m y k myk s v k svk o v v ovv v a s vas s y n syn s v m svm d a k dak y n i yni a a m aam k v z kvz y v k yvk
matchkey_str	article:18193684:2008----::fetfivsaiotepcrmflopamftcdcagiteains
hierarchy_sort_str	2008
publishDate	2008
allfields	10.20538/1682-0363-2008-3-13-19 doi (DE-627)DOAJ084326883 (DE-599)DOAJ8d5cbe0c1c5d4dfbabafa12fb61f6d66 DE-627 ger DE-627 rakwb eng rus V. V. Novitsky verfasserin aut Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease 2008 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The intake of Simvastatin in a dosage of 40 mg daily within two months in patients with ischemia heart disease has caused increase in the general percentage of ω6 fat acids (FA) at a constant level of ω3 FA, that was not accompanied by change of a ratio ω3/ω6 FA. Despite of progressing increase in total concentration of ω7 FA (at women) and increase of a level ω9 FA (at men) during simvastatin treatment at women and at men led to decrease in the total percentage of nonsaturated fat acids concerning corresponding parameters at healthy donors. The Simvastatin treatment was accompanied by increase in blood plasma in patients with ischemia heart disease (and first of all at women) percentage of the separate saturated fat acids, and also their total level. The index of nonsaturation of fat acids of blood plasma is decreased. ишемическая болезнь сердца симвастатин жирные кислоты Medicine R R. S. Karpov verfasserin aut M. Yu. Kotlovsky verfasserin aut S. V. Klemenkov verfasserin aut O. V. Voronkova verfasserin aut V. A. Shulman verfasserin aut S. Yu. Nikulina verfasserin aut S. V. Mashkovskaya verfasserin aut D. A. Kirichenko verfasserin aut Ye. N. Ivtchenko verfasserin aut A. A. Masterova verfasserin aut K. V. Zlodeyev verfasserin aut Yu. V. Kotlovsky verfasserin aut In Бюллетень сибирской медицины Siberian State Medical University (Tomsk), 2016 7(2008), 3, Seite 13-19 (DE-627)1760628204 18193684 nnns volume:7 year:2008 number:3 pages:13-19 https://doi.org/10.20538/1682-0363-2008-3-13-19 kostenfrei https://doaj.org/article/8d5cbe0c1c5d4dfbabafa12fb61f6d66 kostenfrei https://bulletin.ssmu.ru/jour/article/view/3472 kostenfrei https://doaj.org/toc/1682-0363 Journal toc kostenfrei https://doaj.org/toc/1819-3684 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 7 2008 3 13-19
spelling	10.20538/1682-0363-2008-3-13-19 doi (DE-627)DOAJ084326883 (DE-599)DOAJ8d5cbe0c1c5d4dfbabafa12fb61f6d66 DE-627 ger DE-627 rakwb eng rus V. V. Novitsky verfasserin aut Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease 2008 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The intake of Simvastatin in a dosage of 40 mg daily within two months in patients with ischemia heart disease has caused increase in the general percentage of ω6 fat acids (FA) at a constant level of ω3 FA, that was not accompanied by change of a ratio ω3/ω6 FA. Despite of progressing increase in total concentration of ω7 FA (at women) and increase of a level ω9 FA (at men) during simvastatin treatment at women and at men led to decrease in the total percentage of nonsaturated fat acids concerning corresponding parameters at healthy donors. The Simvastatin treatment was accompanied by increase in blood plasma in patients with ischemia heart disease (and first of all at women) percentage of the separate saturated fat acids, and also their total level. The index of nonsaturation of fat acids of blood plasma is decreased. ишемическая болезнь сердца симвастатин жирные кислоты Medicine R R. S. Karpov verfasserin aut M. Yu. Kotlovsky verfasserin aut S. V. Klemenkov verfasserin aut O. V. Voronkova verfasserin aut V. A. Shulman verfasserin aut S. Yu. Nikulina verfasserin aut S. V. Mashkovskaya verfasserin aut D. A. Kirichenko verfasserin aut Ye. N. Ivtchenko verfasserin aut A. A. Masterova verfasserin aut K. V. Zlodeyev verfasserin aut Yu. V. Kotlovsky verfasserin aut In Бюллетень сибирской медицины Siberian State Medical University (Tomsk), 2016 7(2008), 3, Seite 13-19 (DE-627)1760628204 18193684 nnns volume:7 year:2008 number:3 pages:13-19 https://doi.org/10.20538/1682-0363-2008-3-13-19 kostenfrei https://doaj.org/article/8d5cbe0c1c5d4dfbabafa12fb61f6d66 kostenfrei https://bulletin.ssmu.ru/jour/article/view/3472 kostenfrei https://doaj.org/toc/1682-0363 Journal toc kostenfrei https://doaj.org/toc/1819-3684 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 7 2008 3 13-19
allfields_unstemmed	10.20538/1682-0363-2008-3-13-19 doi (DE-627)DOAJ084326883 (DE-599)DOAJ8d5cbe0c1c5d4dfbabafa12fb61f6d66 DE-627 ger DE-627 rakwb eng rus V. V. Novitsky verfasserin aut Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease 2008 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The intake of Simvastatin in a dosage of 40 mg daily within two months in patients with ischemia heart disease has caused increase in the general percentage of ω6 fat acids (FA) at a constant level of ω3 FA, that was not accompanied by change of a ratio ω3/ω6 FA. Despite of progressing increase in total concentration of ω7 FA (at women) and increase of a level ω9 FA (at men) during simvastatin treatment at women and at men led to decrease in the total percentage of nonsaturated fat acids concerning corresponding parameters at healthy donors. The Simvastatin treatment was accompanied by increase in blood plasma in patients with ischemia heart disease (and first of all at women) percentage of the separate saturated fat acids, and also their total level. The index of nonsaturation of fat acids of blood plasma is decreased. ишемическая болезнь сердца симвастатин жирные кислоты Medicine R R. S. Karpov verfasserin aut M. Yu. Kotlovsky verfasserin aut S. V. Klemenkov verfasserin aut O. V. Voronkova verfasserin aut V. A. Shulman verfasserin aut S. Yu. Nikulina verfasserin aut S. V. Mashkovskaya verfasserin aut D. A. Kirichenko verfasserin aut Ye. N. Ivtchenko verfasserin aut A. A. Masterova verfasserin aut K. V. Zlodeyev verfasserin aut Yu. V. Kotlovsky verfasserin aut In Бюллетень сибирской медицины Siberian State Medical University (Tomsk), 2016 7(2008), 3, Seite 13-19 (DE-627)1760628204 18193684 nnns volume:7 year:2008 number:3 pages:13-19 https://doi.org/10.20538/1682-0363-2008-3-13-19 kostenfrei https://doaj.org/article/8d5cbe0c1c5d4dfbabafa12fb61f6d66 kostenfrei https://bulletin.ssmu.ru/jour/article/view/3472 kostenfrei https://doaj.org/toc/1682-0363 Journal toc kostenfrei https://doaj.org/toc/1819-3684 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 7 2008 3 13-19
allfieldsGer	10.20538/1682-0363-2008-3-13-19 doi (DE-627)DOAJ084326883 (DE-599)DOAJ8d5cbe0c1c5d4dfbabafa12fb61f6d66 DE-627 ger DE-627 rakwb eng rus V. V. Novitsky verfasserin aut Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease 2008 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The intake of Simvastatin in a dosage of 40 mg daily within two months in patients with ischemia heart disease has caused increase in the general percentage of ω6 fat acids (FA) at a constant level of ω3 FA, that was not accompanied by change of a ratio ω3/ω6 FA. Despite of progressing increase in total concentration of ω7 FA (at women) and increase of a level ω9 FA (at men) during simvastatin treatment at women and at men led to decrease in the total percentage of nonsaturated fat acids concerning corresponding parameters at healthy donors. The Simvastatin treatment was accompanied by increase in blood plasma in patients with ischemia heart disease (and first of all at women) percentage of the separate saturated fat acids, and also their total level. The index of nonsaturation of fat acids of blood plasma is decreased. ишемическая болезнь сердца симвастатин жирные кислоты Medicine R R. S. Karpov verfasserin aut M. Yu. Kotlovsky verfasserin aut S. V. Klemenkov verfasserin aut O. V. Voronkova verfasserin aut V. A. Shulman verfasserin aut S. Yu. Nikulina verfasserin aut S. V. Mashkovskaya verfasserin aut D. A. Kirichenko verfasserin aut Ye. N. Ivtchenko verfasserin aut A. A. Masterova verfasserin aut K. V. Zlodeyev verfasserin aut Yu. V. Kotlovsky verfasserin aut In Бюллетень сибирской медицины Siberian State Medical University (Tomsk), 2016 7(2008), 3, Seite 13-19 (DE-627)1760628204 18193684 nnns volume:7 year:2008 number:3 pages:13-19 https://doi.org/10.20538/1682-0363-2008-3-13-19 kostenfrei https://doaj.org/article/8d5cbe0c1c5d4dfbabafa12fb61f6d66 kostenfrei https://bulletin.ssmu.ru/jour/article/view/3472 kostenfrei https://doaj.org/toc/1682-0363 Journal toc kostenfrei https://doaj.org/toc/1819-3684 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 7 2008 3 13-19
allfieldsSound	10.20538/1682-0363-2008-3-13-19 doi (DE-627)DOAJ084326883 (DE-599)DOAJ8d5cbe0c1c5d4dfbabafa12fb61f6d66 DE-627 ger DE-627 rakwb eng rus V. V. Novitsky verfasserin aut Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease 2008 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The intake of Simvastatin in a dosage of 40 mg daily within two months in patients with ischemia heart disease has caused increase in the general percentage of ω6 fat acids (FA) at a constant level of ω3 FA, that was not accompanied by change of a ratio ω3/ω6 FA. Despite of progressing increase in total concentration of ω7 FA (at women) and increase of a level ω9 FA (at men) during simvastatin treatment at women and at men led to decrease in the total percentage of nonsaturated fat acids concerning corresponding parameters at healthy donors. The Simvastatin treatment was accompanied by increase in blood plasma in patients with ischemia heart disease (and first of all at women) percentage of the separate saturated fat acids, and also their total level. The index of nonsaturation of fat acids of blood plasma is decreased. ишемическая болезнь сердца симвастатин жирные кислоты Medicine R R. S. Karpov verfasserin aut M. Yu. Kotlovsky verfasserin aut S. V. Klemenkov verfasserin aut O. V. Voronkova verfasserin aut V. A. Shulman verfasserin aut S. Yu. Nikulina verfasserin aut S. V. Mashkovskaya verfasserin aut D. A. Kirichenko verfasserin aut Ye. N. Ivtchenko verfasserin aut A. A. Masterova verfasserin aut K. V. Zlodeyev verfasserin aut Yu. V. Kotlovsky verfasserin aut In Бюллетень сибирской медицины Siberian State Medical University (Tomsk), 2016 7(2008), 3, Seite 13-19 (DE-627)1760628204 18193684 nnns volume:7 year:2008 number:3 pages:13-19 https://doi.org/10.20538/1682-0363-2008-3-13-19 kostenfrei https://doaj.org/article/8d5cbe0c1c5d4dfbabafa12fb61f6d66 kostenfrei https://bulletin.ssmu.ru/jour/article/view/3472 kostenfrei https://doaj.org/toc/1682-0363 Journal toc kostenfrei https://doaj.org/toc/1819-3684 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 7 2008 3 13-19
language	English Russian
source	In Бюллетень сибирской медицины 7(2008), 3, Seite 13-19 volume:7 year:2008 number:3 pages:13-19
sourceStr	In Бюллетень сибирской медицины 7(2008), 3, Seite 13-19 volume:7 year:2008 number:3 pages:13-19
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	ишемическая болезнь сердца симвастатин жирные кислоты Medicine R
isfreeaccess_bool	true
container_title	Бюллетень сибирской медицины
authorswithroles_txt_mv	V. V. Novitsky @@aut@@ R. S. Karpov @@aut@@ M. Yu. Kotlovsky @@aut@@ S. V. Klemenkov @@aut@@ O. V. Voronkova @@aut@@ V. A. Shulman @@aut@@ S. Yu. Nikulina @@aut@@ S. V. Mashkovskaya @@aut@@ D. A. Kirichenko @@aut@@ Ye. N. Ivtchenko @@aut@@ A. A. Masterova @@aut@@ K. V. Zlodeyev @@aut@@ Yu. V. Kotlovsky @@aut@@
publishDateDaySort_date	2008-01-01T00:00:00Z
hierarchy_top_id	1760628204
id	DOAJ084326883
language_de	englisch russisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ084326883</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230410115734.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2008 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.20538/1682-0363-2008-3-13-19</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ084326883</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ8d5cbe0c1c5d4dfbabafa12fb61f6d66</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">rus</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">V. V. Novitsky</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2008</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The intake of Simvastatin in a dosage of 40 mg daily within two months in patients with ischemia heart disease has caused increase in the general percentage of ω6 fat acids (FA) at a constant level of ω3 FA, that was not accompanied by change of a ratio ω3/ω6 FA. Despite of progressing increase in total concentration of ω7 FA (at women) and increase of a level ω9 FA (at men) during simvastatin treatment at women and at men led to decrease in the total percentage of nonsaturated fat acids concerning corresponding parameters at healthy donors. The Simvastatin treatment was accompanied by increase in blood plasma in patients with ischemia heart disease (and first of all at women) percentage of the separate saturated fat acids, and also their total level. The index of nonsaturation of fat acids of blood plasma is decreased.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ишемическая болезнь сердца</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">симвастатин</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">жирные кислоты</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">R. S. Karpov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. Yu. Kotlovsky</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. V. Klemenkov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">O. V. Voronkova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">V. A. Shulman</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. Yu. Nikulina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. V. Mashkovskaya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. A. Kirichenko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ye. N. Ivtchenko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. A. Masterova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">K. V. Zlodeyev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yu. V. Kotlovsky</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Бюллетень сибирской медицины</subfield><subfield code="d">Siberian State Medical University (Tomsk), 2016</subfield><subfield code="g">7(2008), 3, Seite 13-19</subfield><subfield code="w">(DE-627)1760628204</subfield><subfield code="x">18193684</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:7</subfield><subfield code="g">year:2008</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:13-19</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.20538/1682-0363-2008-3-13-19</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/8d5cbe0c1c5d4dfbabafa12fb61f6d66</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://bulletin.ssmu.ru/jour/article/view/3472</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1682-0363</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1819-3684</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">7</subfield><subfield code="j">2008</subfield><subfield code="e">3</subfield><subfield code="h">13-19</subfield></datafield></record></collection>
author	V. V. Novitsky
spellingShingle	V. V. Novitsky misc ишемическая болезнь сердца misc симвастатин misc жирные кислоты misc Medicine misc R Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease
authorStr	V. V. Novitsky
ppnlink_with_tag_str_mv	@@773@@(DE-627)1760628204
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut aut aut aut aut aut aut aut
collection	DOAJ
remote_str	true
illustrated	Not Illustrated
issn	18193684
topic_title	Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease ишемическая болезнь сердца симвастатин жирные кислоты
topic	misc ишемическая болезнь сердца misc симвастатин misc жирные кислоты misc Medicine misc R
topic_unstemmed	misc ишемическая болезнь сердца misc симвастатин misc жирные кислоты misc Medicine misc R
topic_browse	misc ишемическая болезнь сердца misc симвастатин misc жирные кислоты misc Medicine misc R
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Бюллетень сибирской медицины
hierarchy_parent_id	1760628204
hierarchy_top_title	Бюллетень сибирской медицины
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)1760628204
title	Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease
ctrlnum	(DE-627)DOAJ084326883 (DE-599)DOAJ8d5cbe0c1c5d4dfbabafa12fb61f6d66
title_full	Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease
author_sort	V. V. Novitsky
journal	Бюллетень сибирской медицины
journalStr	Бюллетень сибирской медицины
lang_code	eng rus
isOA_bool	true
recordtype	marc
publishDateSort	2008
contenttype_str_mv	txt
container_start_page	13
author_browse	V. V. Novitsky R. S. Karpov M. Yu. Kotlovsky S. V. Klemenkov O. V. Voronkova V. A. Shulman S. Yu. Nikulina S. V. Mashkovskaya D. A. Kirichenko Ye. N. Ivtchenko A. A. Masterova K. V. Zlodeyev Yu. V. Kotlovsky
container_volume	7
format_se	Elektronische Aufsätze
author-letter	V. V. Novitsky
doi_str_mv	10.20538/1682-0363-2008-3-13-19
author2-role	verfasserin
title_sort	effect of simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease
title_auth	Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease
abstract	The intake of Simvastatin in a dosage of 40 mg daily within two months in patients with ischemia heart disease has caused increase in the general percentage of ω6 fat acids (FA) at a constant level of ω3 FA, that was not accompanied by change of a ratio ω3/ω6 FA. Despite of progressing increase in total concentration of ω7 FA (at women) and increase of a level ω9 FA (at men) during simvastatin treatment at women and at men led to decrease in the total percentage of nonsaturated fat acids concerning corresponding parameters at healthy donors. The Simvastatin treatment was accompanied by increase in blood plasma in patients with ischemia heart disease (and first of all at women) percentage of the separate saturated fat acids, and also their total level. The index of nonsaturation of fat acids of blood plasma is decreased.
abstractGer	The intake of Simvastatin in a dosage of 40 mg daily within two months in patients with ischemia heart disease has caused increase in the general percentage of ω6 fat acids (FA) at a constant level of ω3 FA, that was not accompanied by change of a ratio ω3/ω6 FA. Despite of progressing increase in total concentration of ω7 FA (at women) and increase of a level ω9 FA (at men) during simvastatin treatment at women and at men led to decrease in the total percentage of nonsaturated fat acids concerning corresponding parameters at healthy donors. The Simvastatin treatment was accompanied by increase in blood plasma in patients with ischemia heart disease (and first of all at women) percentage of the separate saturated fat acids, and also their total level. The index of nonsaturation of fat acids of blood plasma is decreased.
abstract_unstemmed	The intake of Simvastatin in a dosage of 40 mg daily within two months in patients with ischemia heart disease has caused increase in the general percentage of ω6 fat acids (FA) at a constant level of ω3 FA, that was not accompanied by change of a ratio ω3/ω6 FA. Despite of progressing increase in total concentration of ω7 FA (at women) and increase of a level ω9 FA (at men) during simvastatin treatment at women and at men led to decrease in the total percentage of nonsaturated fat acids concerning corresponding parameters at healthy donors. The Simvastatin treatment was accompanied by increase in blood plasma in patients with ischemia heart disease (and first of all at women) percentage of the separate saturated fat acids, and also their total level. The index of nonsaturation of fat acids of blood plasma is decreased.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ
container_issue	3
title_short	Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease
url	https://doi.org/10.20538/1682-0363-2008-3-13-19 https://doaj.org/article/8d5cbe0c1c5d4dfbabafa12fb61f6d66 https://bulletin.ssmu.ru/jour/article/view/3472 https://doaj.org/toc/1682-0363 https://doaj.org/toc/1819-3684
remote_bool	true
author2	R. S. Karpov M. Yu. Kotlovsky S. V. Klemenkov O. V. Voronkova V. A. Shulman S. Yu. Nikulina S. V. Mashkovskaya D. A. Kirichenko Ye. N. Ivtchenko A. A. Masterova K. V. Zlodeyev Yu. V. Kotlovsky
author2Str	R. S. Karpov M. Yu. Kotlovsky S. V. Klemenkov O. V. Voronkova V. A. Shulman S. Yu. Nikulina S. V. Mashkovskaya D. A. Kirichenko Ye. N. Ivtchenko A. A. Masterova K. V. Zlodeyev Yu. V. Kotlovsky
ppnlink	1760628204
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.20538/1682-0363-2008-3-13-19
up_date	2024-07-03T22:25:42.616Z
_version_	1803598474896211968
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ084326883</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230410115734.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2008 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.20538/1682-0363-2008-3-13-19</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ084326883</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ8d5cbe0c1c5d4dfbabafa12fb61f6d66</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">rus</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">V. V. Novitsky</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2008</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The intake of Simvastatin in a dosage of 40 mg daily within two months in patients with ischemia heart disease has caused increase in the general percentage of ω6 fat acids (FA) at a constant level of ω3 FA, that was not accompanied by change of a ratio ω3/ω6 FA. Despite of progressing increase in total concentration of ω7 FA (at women) and increase of a level ω9 FA (at men) during simvastatin treatment at women and at men led to decrease in the total percentage of nonsaturated fat acids concerning corresponding parameters at healthy donors. The Simvastatin treatment was accompanied by increase in blood plasma in patients with ischemia heart disease (and first of all at women) percentage of the separate saturated fat acids, and also their total level. The index of nonsaturation of fat acids of blood plasma is decreased.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ишемическая болезнь сердца</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">симвастатин</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">жирные кислоты</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">R. S. Karpov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. Yu. Kotlovsky</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. V. Klemenkov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">O. V. Voronkova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">V. A. Shulman</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. Yu. Nikulina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. V. Mashkovskaya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. A. Kirichenko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ye. N. Ivtchenko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. A. Masterova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">K. V. Zlodeyev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yu. V. Kotlovsky</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Бюллетень сибирской медицины</subfield><subfield code="d">Siberian State Medical University (Tomsk), 2016</subfield><subfield code="g">7(2008), 3, Seite 13-19</subfield><subfield code="w">(DE-627)1760628204</subfield><subfield code="x">18193684</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:7</subfield><subfield code="g">year:2008</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:13-19</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.20538/1682-0363-2008-3-13-19</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/8d5cbe0c1c5d4dfbabafa12fb61f6d66</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://bulletin.ssmu.ru/jour/article/view/3472</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1682-0363</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1819-3684</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">7</subfield><subfield code="j">2008</subfield><subfield code="e">3</subfield><subfield code="h">13-19</subfield></datafield></record></collection>
score	7.4010057

Nicht das Richtige dabei?

Schreiben Sie uns!

Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?